Cancer Imaging is the official journal of the International Cancer Imaging Society (ICIS)
Citation: Cancer Imaging 2015 1:10010077
Page 13 of 14
Citation: Cancer Imaging 2015 1:10010077
Citation: Cancer Imaging 2015 1:10010064
Citation: Cancer Imaging 2015 1:10010044
Citation: Cancer Imaging 2015 1:10010035
Citation: Cancer Imaging 2015 1:10010028
Citation: Cancer Imaging 2015 1:10010025
Citation: Cancer Imaging 2015 1:10010018
Citation: Cancer Imaging 2015 1:10010005
The peritoneum is the largest and most complexly arranged serous membrane in the body. The potential peritoneal spaces, the peritoneal reflections forming peritoneal ligaments, mesenteries, omenta, and the nat...
Citation: Cancer Imaging 2015 1:10286
In patients with liver cirrhosis, arterial phase enhancement of nodular lesions on helical-CT is currently considered to be highly predictive of malignancy. We report the spontaneous regression of a hypervascu...
Citation: Cancer Imaging 2015 1:10279
Citation: Cancer Imaging 2015 2:26
Citation: Cancer Imaging 2015 2:25
Citation: Cancer Imaging 2015 2:24
Citation: Cancer Imaging 2015 2:23
Citation: Cancer Imaging 2015 2:22
Citation: Cancer Imaging 2015 2:21
Citation: Cancer Imaging 2015 2:20
Citation: Cancer Imaging 2015 2:19
Citation: Cancer Imaging 2015 2:18
It is important to distinguish liver metastases from incidental benign liver lesions which may be present in patients with cancer. In a minority of cases, sonography or CT may be sufficient to characterise ben...
Citation: Cancer Imaging 2015 2:17
Citation: Cancer Imaging 2015 2:16
Multiple myeloma is characterised by a progressive proliferation of malignant plasma cells usually initiating in the bone marrow. The most common manifestations of this disease are bone involvement, renal dise...
Citation: Cancer Imaging 2015 2:15
Citation: Cancer Imaging 2015 2:14
In 1923 Masson described a neo-plastic process consisting of papillary hyperplasia of the vascular endothelial cells, with a consequent obliteration of the vascular lumen, followed by degenerative changes. He ...
Citation: Cancer Imaging 2015 2:14
Citation: Cancer Imaging 2015 2:13
This contribution presents an approach to diagnosis in patients known to have malignant disease, who present with neurological symptoms and signs which may be a result of epidural spinal cord compression or in...
Citation: Cancer Imaging 2015 2:13
Citation: Cancer Imaging 2015 2:12
Citation: Cancer Imaging 2015 2:12
Citation: Cancer Imaging 2015 2:11
Citation: Cancer Imaging 2015 2:11
Citation: Cancer Imaging 2015 2:10
Citation: Cancer Imaging 2015 2:10
Citation: Cancer Imaging 2015 2:9
Citation: Cancer Imaging 2015 2:9
Citation: Cancer Imaging 2015 2:8
A 28-year-old man presented with a seven-day history of testicular pain. Physical examination revealed a mass in the lower pole of the left testis. This mass was a tumour suspect on scrotal ultrasound and MRI....
Citation: Cancer Imaging 2015 2:8
Citation: Cancer Imaging 2015 2:7
In the management of patients with lymphoma, imaging is essential not only for diagnosis but also to define prognosis and treatment by staging. Imaging is also used to assess the response to treatment that may...
Citation: Cancer Imaging 2015 2:7
Citation: Cancer Imaging 2015 2:6
The evaluation of bone marrow of patients treated for cancer is complicated by age-related changes in the distribution of normal (red) and fatty (yellow) marrow and by the changes induced by treatments. The tr...
Citation: Cancer Imaging 2015 2:6
Citation: Cancer Imaging 2015 2:5
The ability to demonstrate tumour foci that are undetected by conventional imaging has resulted in the emergence of positron emission tomography (PET) as a valuable clinical tool in oncology. This article desc...
Citation: Cancer Imaging 2015 2:5
Citation: Cancer Imaging 2015 2:4
Nuclear medicine techniques designed to identify bone metastases are reviewed. They include planar and whole body, single photon emission tomography (SPET), F-18 Fluorine and FDG, deoxyglucose, positron emissi...
Citation: Cancer Imaging 2015 2:4
Citation: Cancer Imaging 2015 2:3
There is no set protocol for imaging prostate cancer, and a selection of a particular modality (TRUS, CT or MRI) often depends on the equipment and local expertise available. None of the imaging modality is pe...
Citation: Cancer Imaging 2015 2:3
Citation: Cancer Imaging 2015 2:2
Citation: Cancer Imaging 2015 2:2
Citation: Cancer Imaging 2015 2:1
Early detection of liver metastases improves outcome in patients treated by chemotherapy, and is also associated with better survival in patients treated surgically. Large liver metastases (greater than about ...
Citation: Cancer Imaging 2015 2:1
Cancer Imaging is the official journal of the International Cancer Imaging Society (ICIS)
Speed
77 days to first decision for reviewed manuscripts only
61 days to first decision for all manuscripts
133 days from submission to acceptance
15 days from acceptance to publication
Citation Impact
2.193 - 2-year Impact Factor
2.885 - 5-year Impact Factor
1.382 - Source Normalized Impact per Paper (SNIP)
0.939 - SCImago Journal Rank (SJR)
Usage
360,800 Downloads
273 Altmetric Mentions